HEALTH CARE TECHNOLOGY INDUSTRY

exini diagnostics ab-a shs
(EXINA:Stockholm)

Last --

Change Today 0.00 / 0.00%

Volume 0.0

EXINA On Other Exchanges

Symbol

Exchange

EXINA:SS

Stockholm

All times are local (Market data is delayed by at least 15 minutes).

exini diagnostics ab-a shs (EXINA) Snapshot

Open --		Previous Close --
Day High --		Day Low --
52 Week High -- - --		52 Week Low -- - --
Market Cap --		Average Volume 10 Days 0.0
EPS TTM --		Shares Outstanding 0.0
EX-Date --		P/E TM --
Dividend --		Dividend Yield --

Current Stock Chart for EXINI DIAGNOSTICS AB-A SHS (EXINA)

EXINA:SS Historical Stock Quote
EXINA:SS Advanced Stock Chart

Related News

No related news articles were found.

exini diagnostics ab-a shs (EXINA) Related Businessweek News

No Related Businessweek News Found

exini diagnostics ab-a shs (EXINA) Details

EXINI Diagnostics AB (publ) provides software solutions for medical decision support in hospitals worldwide. Its software products comprise EXINI bone for diagnosing prostate cancer and analyzing bone scintigraphy; EXINI heart software that offers analysis of myocardial perfusion scintigraphy; EXINI brain software for cerebral blood flow imaging; EXINI brain for diagnosing dementia by processing cerebral blood flow scans; and EXINI dat for diagnosing Parkinsonian syndromes using quantification of striatal uptake. The company was founded in 1999 and is based in Lund, Sweden.

Detailed EXINA:SS Company Description...

www.exini.com

Founded in 1999

exini diagnostics ab-a shs (EXINA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

exini diagnostics ab-a shs (EXINA) Key Developments

EXINI Diagnostics AB to Report Fiscal Year 2012 Results on May 14, 2013

Feb 13 13

EXINI Diagnostics AB announced that they will report fiscal year 2012 results on May 14, 2013

EXINI Diagnostics AB to Report Q1, 2013 Results on Apr 23, 2013

Feb 13 13

EXINI Diagnostics AB announced that they will report Q1, 2013 results on Apr 23, 2013

EXINI Diagnostics AB Reaches New Development Agreement with Fujifilm RI Pharma Co. Ltd. Related to EXINI Bone™

Feb 21 12

EXINI Diagnostics AB has reached an agreement with Fujifilm RI Pharma Co. Ltd. to along with some of Japan's university hospitals and prefectural cancer centers develop the next generation of EXINI boneTM (Bonenavi). The agreement is a step to further strengthen the cooperation between the companies and the successful positioning of the product in Japan, while the software wil improve even more. The project will be executed by EXINI together with FUJIFILM RI Pharma. In addition the project will use well known university hospitals and prefectural cancer centers in Japan, to further develop and enhance the artificial intelligence and other important features of the software. The collaboration combines EXINI's deep knowledge in machine learning and clinical database with FUJIFILM's application expertise and close contact with end users. The project will be partly funded by FUJIFILM RI Pharma and is expected to last 12 months.